Valérie Taly's Biography

• Home
• |
• Registration
• |
• Submissions
  • Submission Guidelines
• |
• Agenda
• |
• Exhibition
• |
• Venue
• |
• Co-Located Conferences
• |
• Media
• |

Droplet-based Microfluidics for Cancer Research: Application for Cancer Patient Follow-up

Monday, 28 June 2021 at 11:30

Add to Calendar ▼2021-06-28 11:30:002021-06-28 12:30:00Europe/LondonDroplet-based Microfluidics for Cancer Research: Application for Cancer Patient Follow-upLab-on-a-Chip and Microfluidics Europe 2021 in Rotterdam, The NetherlandsRotterdam, The NetherlandsSELECTBIOenquiries@selectbiosciences.com

Droplet-based microfluidics has led to the development of highly powerful tools with great potential in High-Throughput Screening where individual assays are compartmentalized within aqueous droplets acting as independent microreactors. Thanks to the combination of a decrease of assay volume and an increase of throughput, this technology goes beyond the capacities of conventional screening systems. Added to the flexibility and versatility of platform designs, such progresses in the manipulation of sub-nanoliter droplets has allowed to dramatically increase experimental level of control and precision. The presentation will aim at demonstrating through selected example, the great potential of this technology for biotechnology and cancer research. We will also show how by combining microfluidic systems and clinical advances in molecular diagnostic we have developed an original method to perform millions of single molecule PCR in parallel to detect and quantify a minority of target sequences in complex mixture of DNA with a sensitivity unreachable by conventional procedures. To demonstrate the pertinence of our procedures to overcome clinical oncology challenges, the results of clinical studies will be presented. In particular, applications of ddPCR to the follow-up of both advanced and localized digestive cancers will be presented. Finally, we will also show application of these technology for Covid19 patients.